Literature DB >> 10649170

Blood flow and the degree of shunting through the ductus venosus in the human fetus.

T Kiserud1, S Rasmussen, S Skulstad.   

Abstract

OBJECTIVES: Our goal was to determine the degree of shunting through the ductus venosus in the human fetus and its possible association with fetal growth. STUDY
DESIGN: Blood flow in the umbilical vein and the fetal ductus venosus was measured in 197 low-risk pregnancies in a cross-sectional ultrasonographic study at a gestational age of 18 to 41 weeks. The degree of shunting was compared to birth weight and ponderal index.
RESULTS: The average fraction shunted through the ductus venosus was 28% to 32% at 18 to 20 weeks, decreased to 22% at 25 weeks, and reached 18% at 31 weeks (with wide ranges expressed in the 10th and 90th percentiles). Fetuses <10th percentile for birth weight had significantly more shunting (1.4%) than those >90th percentile (95% confidence interval, 0.1%-2.7%; P =.04).
CONCLUSIONS: In the human fetus a higher proportion of umbilical blood is directed to the liver and less is shunted through the ductus venosus, in comparison with what has previously been shown in animal experiments.

Entities:  

Mesh:

Year:  2000        PMID: 10649170     DOI: 10.1016/s0002-9378(00)70504-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  31 in total

1.  Two ductus venosus: a previously unreported anomaly.

Authors:  Mohammed Firdouse; Arnav Agarwal; Bharadwaj Pindiprolu; Tapas Mondal
Journal:  J Ultrasound       Date:  2014-04-16

Review 2.  Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.

Authors:  André Dallmann; Ibrahim Ince; Michaela Meyer; Stefan Willmann; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-11       Impact factor: 6.447

3.  Fetal Physiologically Based Pharmacokinetic Models: Systems Information on Fetal Cardiac Output and Its Distribution to Different Organs during Development.

Authors:  Khaled Abduljalil; Xian Pan; Ruth Clayton; Trevor N Johnson; Masoud Jamei
Journal:  Clin Pharmacokinet       Date:  2021-01-24       Impact factor: 6.447

4.  Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.

Authors:  Zufei Zhang; Marjorie Z Imperial; Gabriela I Patilea-Vrana; Janak Wedagedera; Lu Gaohua; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2017-06-06       Impact factor: 3.922

Review 5.  Anesthesia for myelomeningocele surgery in fetus.

Authors:  Juan Carlos Devoto; Juan Luis Alcalde; Felipe Otayza; Waldo Sepulveda
Journal:  Childs Nerv Syst       Date:  2017-05-25       Impact factor: 1.475

Review 6.  Diagnosis and management of heart failure in the fetus.

Authors:  B Davey; A Szwast; J Rychik
Journal:  Minerva Pediatr       Date:  2012-10       Impact factor: 1.312

7.  Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition.

Authors:  Antonio E Frias; Terry K Morgan; Anne E Evans; Juha Rasanen; Karen Y Oh; Kent L Thornburg; Kevin L Grove
Journal:  Endocrinology       Date:  2011-03-29       Impact factor: 4.736

8.  Prospective association of fetal liver blood flow at 30 weeks gestation with newborn adiposity.

Authors:  Satoru Ikenoue; Feizal Waffarn; Masanao Ohashi; Kaeko Sumiyoshi; Chigusa Ikenoue; Claudia Buss; Daniel L Gillen; Hyagriv N Simhan; Sonja Entringer; Pathik D Wadhwa
Journal:  Am J Obstet Gynecol       Date:  2017-04-20       Impact factor: 8.661

9.  Fetal dose estimates for (18)F-fluoro-L-thymidine using a pregnant monkey model.

Authors:  Rachel M Bartlett; Robert J Nickles; Todd E Barnhart; Bradley T Christian; James E Holden; Onofre T DeJesus
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

10.  Integration of Life-Stage Physiologically Based Pharmacokinetic Models with Adverse Outcome Pathways and Environmental Exposure Models to Screen for Environmental Hazards.

Authors:  Hisham El-Masri; Nicole Kleinstreuer; Ronald N Hines; Linda Adams; Tamara Tal; Kristin Isaacs; Barbara A Wetmore; Yu-Mei Tan
Journal:  Toxicol Sci       Date:  2016-05-04       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.